DIFFERENTIAL-EFFECTS OF REPEATED ADMINISTRATION OF NOVEL ANTIPSYCHOTIC-DRUGS ON THE ACTIVITY OF MIDBRAIN DOPAMINE NEURONS IN THE RAT

被引:59
作者
SKARSFELDT, T
机构
[1] Pharmacological Research, Research and Development, H. Lundbeck A/S, DK-2500 Copenhagen-Valby
关键词
RISPERIDONE; OLANZAPINE; SEROQUEL; ZIPRASIDONE; AMPEROZIDE; SCHIZOPHRENIA; VENTRAL TEGMENTAL AREA; SUBSTANTIA NIGRA PARS COMPACTA; (RAT);
D O I
10.1016/0014-2999(95)00260-R
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Five potential antipsychotics (i.e, risperidone, olanzapine, seroquel, ziprasidone and amperozide) were given daily for 21 days to rats and the effect on the number of spontaneously active dopamine neurons in ventral tegmental area and substantia nigra pars compacta was determined. Standard electrophysiological measurements (i.e. single unit recording technique) were used. Risperidone, olanzapine and amperozide showed some selectivity (at one particular dose) for decreasing the number of active dopamine neurons in the ventral tegmental area. However, risperidone induced a U-shaped dose-response curve. The highest dose of amperozide inhibited the activity in substantia nigra pars compacta, showing a liability to induce extrapyramidal side-effects. Seroquel and ziprasidone inhibited the activity in both areas indicating a classical antipsychotic profile (i.e. high liability to cause extrapyramidal side-effects).
引用
收藏
页码:289 / 294
页数:6
相关论文
共 38 条
[1]   EFFECTS OF AMPEROZIDE IN SCHIZOPHRENIA - AN OPEN STUDY OF A POTENT 5-HT2 RECEPTOR ANTAGONIST [J].
AXELSSON, R ;
NILSSON, A ;
CHRISTENSSON, E ;
BJORK, A .
PSYCHOPHARMACOLOGY, 1991, 104 (03) :287-292
[2]  
BEASLEY CM, 1993, DEC ACNP
[3]   DOSE-DEPENDENT OCCUPANCY OF CENTRAL DOPAMINE-D(2) RECEPTORS BY THE NOVEL NEUROLEPTIC CP-88,059-01 - A STUDY USING POSITRON EMISSION TOMOGRAPHY AND C-11 RACLOPRIDE [J].
BENCH, CJ ;
LAMMERTSMA, AA ;
DOLAN, RJ ;
GRASBY, PM ;
WARRINGTON, SJ ;
GUNN, K ;
CUDDIGAN, M ;
TURTON, DJ ;
OSMAN, S ;
FRACKOWIAK, RSJ .
PSYCHOPHARMACOLOGY, 1993, 112 (2-3) :308-314
[4]  
BORISON RL, 1992, PSYCHOPHARMACOL BULL, V28, P213
[5]   CLOZAPINE - AN ATYPICAL NEUROLEPTIC [J].
BRUHWYLER, J ;
CHLEIDE, E ;
MERCIER, M .
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 1990, 14 (04) :357-363
[6]   ACUTE AND CHRONIC HALOPERIDOL TREATMENT - COMPARISON OF EFFECTS ON NIGRAL DOPAMINERGIC CELL ACTIVITY [J].
BUNNEY, BS ;
GRACE, AA .
LIFE SCIENCES, 1978, 23 (16) :1715-1727
[7]  
BUNNEY BS, 1973, J PHARMACOL EXP THER, V185, P560
[8]   DOUBLE-BLIND COMPARISON OF RISPERIDONE AND HALOPERIDOL IN SCHIZOPHRENIC AND SCHIZOAFFECTIVE PSYCHOSES [J].
CESKOVA, E ;
SVESTKA, J .
PHARMACOPSYCHIATRY, 1993, 26 (04) :121-124
[9]  
CHIODO LA, 1985, J NEUROSCI, V5, P2539
[10]  
CHOUINARD G, 1993, J CLIN PSYCHOPHARM, V13, P25